Stay updated on Safety of Iptacopan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety of Iptacopan in IgA Nephropathy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.5.2 has been added to the history. Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed on the page. This reflects a platform version update without changes to the study record data.SummaryDifference0.1%

- Check47 days agoChange DetectedThe history now shows a new revision entry v3.4.3 and removes the previous revision v3.4.2.SummaryDifference0.1%

- Check61 days agoChange DetectedOn 2026-02-23, Contacts/Locations and Study Status were added to the record history, and a deletion occurred on 2026-01-29.SummaryDifference0.5%

- Check76 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and a funding/operating status notice (and the older v3.4.1 entry) were removed. These are administrative updates to the revision history and do not affect study data or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check83 days agoChange DetectedA new version (v3.4.1, posted 2026-01-29) adds updates to Study Status and Contacts/Locations plus a government funding notice. The prior version (v3.4.0, 2025-12-24) was deleted.SummaryDifference1%

Stay in the know with updates to Safety of Iptacopan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.